Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001178913-11-003007
Filing Date
2011-11-09
Accepted
2011-11-09 16:15:37
Documents
11
Period of Report
2011-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q zk1110603.htm 10-Q 778321
2 EXHIBIT 31.1 exhibit_31-1.htm EX-31.1 10220
3 EXHIBIT 31.2 exhibit_31-2.htm EX-31.2 9874
4 EXHIBIT 32.1 exhibit_32-1.htm EX-32.1 5395
5 EXHIBIT 32.2 exhibit_32-2.htm EX-32.2 5528
  Complete submission text file 0001178913-11-003007.txt   2956136

Data Files

Seq Description Document Type Size
6 INSTANCE DOCUMENT psti-20110930.xml EX-101.INS 396212
7 TAXONOMY EXTENSION SCHEMA psti-20110930.xsd EX-101.SCH 20717
8 TAXONOMY EXTENSION CALCULATION LINKBASE psti-20110930_cal.xml EX-101.CAL 49388
9 TAXONOMY EXTENSION LABEL LINKBASE psti-20110930_def.xml EX-101.DEF 16457
10 TAXONOMY EXTENSION PRESENTATION LINKBASE psti-20110930_lab.xml EX-101.LAB 286532
11 TAXONOMY EXTENSION DEFINITION LINKBASE psti-20110930_pre.xml EX-101.PRE 106409
Mailing Address MATAM ADVANCED TECHNOLOGY PARK BUILDING NO. 20 HAIFA L3 31905
Business Address MATAM ADVANCED TECHNOLOGY PARK BUILDING NO. 20 HAIFA L3 31905 972-74-710-7171
PLURISTEM THERAPEUTICS INC (Filer) CIK: 0001158780 (see all company filings)

EIN.: 980351734 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-31392 | Film No.: 111191875
SIC: 2836 Biological Products, (No Diagnostic Substances)